share_log

Altimmune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(5.51%)

Altimmune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(5.51%)

Altimmune | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(5.51%)
美股sec公告 ·  07/10 06:39
Moomoo AI 已提取核心信息
State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a significant ownership stake in Altimmune Inc., a biopharmaceutical company. According to the filing, State Street Corporation has shared voting power over 3,667,576 shares and shared dispositive power over 3,909,286 shares of Altimmune's common stock. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Altimmune Inc. The subsidiaries of State Street Corporation listed in the filing as beneficial owners of the securities include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as investment advisors (IA).
State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a significant ownership stake in Altimmune Inc., a biopharmaceutical company. According to the filing, State Street Corporation has shared voting power over 3,667,576 shares and shared dispositive power over 3,909,286 shares of Altimmune's common stock. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Altimmune Inc. The subsidiaries of State Street Corporation listed in the filing as beneficial owners of the securities include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as investment advisors (IA).
总部位于马萨诸塞州波士顿的金融服务和银行控股公司道富银行于2024年6月30日向美国证券交易委员会（SEC）提交了修订后的13G表格，表明其对生物制药公司altimmune Inc.拥有重要持股。根据提交，道富银行对3667576股altimmune普通股拥有共同投票权和3909286股共同支配权。申报称这些股份是在业务正常运作过程中获得的，目的不是为了改变或影响altimmune Inc的控制。在申报中列出了道富银行的子公司，包括SSGA Funds Management，Inc.，State Street Global Advisors Europe Limited，State Street Global Advisors Limited和State Street Global Advisors Trust Company，均被分类为投资顾问（IA）。
总部位于马萨诸塞州波士顿的金融服务和银行控股公司道富银行于2024年6月30日向美国证券交易委员会（SEC）提交了修订后的13G表格，表明其对生物制药公司altimmune Inc.拥有重要持股。根据提交，道富银行对3667576股altimmune普通股拥有共同投票权和3909286股共同支配权。申报称这些股份是在业务正常运作过程中获得的，目的不是为了改变或影响altimmune Inc的控制。在申报中列出了道富银行的子公司，包括SSGA Funds Management，Inc.，State Street Global Advisors Europe Limited，State Street Global Advisors Limited和State Street Global Advisors Trust Company，均被分类为投资顾问（IA）。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息